Moores Cancer Center at UC San Diego Health is using advanced imaging, genomics, personalized medicine and new therapies to treat patients like Brian McCloskey, who has stage IV prostate cancer.
Addressing concerns about gene-drive releases in the wild, UC San Diego scientists and their colleagues have developed two new genetic systems that halt or eliminate gene drives after release. The details are published in the journal Molecular Cell.
A consortium of 12 health systems, led by UC San Diego Health, introduces COVID19questions.org, a site where clinicians, researchers, patients and the general public are invited to submit questions that could be answered by COVID-19 patient medical record data from 200+ hospitals.
Early detection and intervention stanched the first known introductions of the SARS-CoV-2 virus into North America and Europe, validating the effectiveness of quick, comprehensive testing and contact tracing, but inadequate public health measures allowed the virus to take hold.
UC San Diego Health is the first hospital on the West Coast to perform heart transplant surgery from a donor after circulatory death using a new portable organ care system. The investigational procedure could significantly decrease transplant waiting list times and improve patient outcomes.
UC San Diego researchers discovered that the SARS-CoV-2 virus can’t grab hold of cell receptor ACE2 without a carbohydrate called heparan sulfate, which is also found on lung cell surfaces — disrupting that interaction with a repurposed drug may help treat COVID-19.
The U.S. News and World Report Best Colleges Guidebook ranks the University of California San Diego the nation’s 8th best public university, up two spots compared to last year. The school also ranks 15th among the best colleges for veterans for participating in federal initiatives helping veterans…
UC San Diego Health continues to expand health care services by opening a new clinic located at 6030 Village Way in Pacific Highlands Ranch. The clinic offers primary care and women’s health services.
UC San Diego researchers demonstrate that one dose of their version of CRISR gene editing can chew up toxic RNA and almost completely reverse symptoms in a mouse model of myotonic dystrophy, a type of adult-onset muscular dystrophy.
Today, California approved a new voluntary pilot program that uses Apple and Google smartphone technology to help rapidly control COVID-19 outbreaks. The program will launch on the campus of UC San Diego for any students and employees who opt in.